NCT04551911Phase 2Completed

Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

Study sponsor: OPKO Health, Inc. · OPK

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2021-10-08Actual
Enrollment · participants171Actual
Source updated2024-05-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview